Fundz

Ourotech, Inc. Pear Bio reported raising $4.59 Million in an initial SEC Form D filing, from an offering of $4.75 Million

PRIVATEOct 29, 2021$4.6M of $4.7M raised

Amount Raised

$4.59 Million

$4.59 Million sold, per SEC Form D (first sale Oct 29, 2021)

Round Type

Seed

United KingdomBiotechnology

Quick answer

OUROTECH, INC.- PEAR BIO raised $4.59 Million in a Seed round, dated October 29, 2021. OUROTECH, INC.- PEAR BIO is based in United Kingdom.

How much did OUROTECH, INC.- PEAR BIO raise?
OUROTECH, INC.- PEAR BIO raised $4.59 Million in a Seed round on October 29, 2021.
What does OUROTECH, INC.- PEAR BIO do?
Pear Bio is a computational biology company that uses organ-on-a-chip and computer vision technology to recreate, visualize and compute the human tumor microenvironment and its effects on cancer progression.
Where is OUROTECH, INC.- PEAR BIO based and how big is it?
OUROTECH, INC.- PEAR BIO is based in United Kingdom.
Who are the decision-makers at OUROTECH, INC.- PEAR BIO?
Fundz holds 1 contact at OUROTECH, INC.- PEAR BIO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as OUROTECH, INC.- PEAR BIO that raised within 45 days of this round, from Fundz verified event records.

  • LONGEVERON LLC raised $20M on December 13, 2021.
  • Memgen, Inc. raised $9.8M on December 13, 2021.
  • OncoMyx Therapeutics, Inc. raised $50M on December 13, 2021.
  • Accellix raised $10M (Funding Round) on December 13, 2021.
  • Memo Therapeutics AG raised an undisclosed amount (Funding Round) on December 13, 2021.
  • Cocoon Biotech Inc. raised $385K (Seed) on December 13, 2021.

Who to call at OUROTECH, INC.- PEAR BIO, and when

A new round usually means OUROTECH, INC.- PEAR BIO is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day OUROTECH, INC.- PEAR BIO raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at OUROTECH, INC.- PEAR BIO, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at OUROTECH, INC.- PEAR BIO. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

OUROTECH, INC.- PEAR BIO

Location

84 WOOD LANE

United Kingdom

About

Pear Bio is a computational biology company that uses organ-on-a-chip and computer vision technology to recreate, visualize and compute the human tumor microenvironment and its effects on cancer progression. We are building an atlas of cancer progression to help research hospitals/pharma test experimental drugs and to help clinicians evaluate potential treatment options for each patient to improve outcomes. Our technology is applicable across solid tumors and we are currently working on a pipeline of biomarker negative cancers, with triple negative breast cancer as the lead indication. Our team has experience in big pharma and R&D tools, and our medical advisory board includes oncologists from MD Anderson, Imperial College London, Stanford University Medical Center and UCSF.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment OUROTECH, INC.- PEAR BIO raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts3 people are listed at OUROTECH, INC.- PEAR BIO. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for OUROTECH, INC.- PEAR BIO's next move

See what Strategic adds

OUROTECH, INC.- PEAR BIO raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.